TrialView: An AI-powered Visual Analytics System for Temporal Event Data in Clinical Trials

Abstract: Randomized controlled trials (RCT) are the gold standards for evaluating the efficacy and safety of therapeutic interventions in human subjects. In addition to the pre-specified endpoints, trial participants' experience reveals the time course of the intervention. Few analytical tools exist to summarize and visualize the individual experience of trial participants. Visual analytics allows integrative examination of temporal event patterns of patient experience, thus generating insights for better care decisions. Towards this end, we introduce TrialView, an information system that combines graph AI and visual analytics to enhance the dissemination of trial data. TrialView offers four distinct yet interconnected views: Individual, Cohort, Progression, and Statistics, enabling an interactive exploration of individual and group-level data. The TrialView system is a general-purpose analytical tool for a broad class of clinical trials. The system is powered by graph AI, knowledge-guided clustering, explanatory modeling, and graph-based agglomeration algorithms. We demonstrate the system's effectiveness in analyzing temporal event data through a case study.

• The paper presents a novel system integrating AI and visual analytics to cluster and analyze temporal event data from clinical trials.
• It employs both graph transformer autoencoders and hierarchical clustering to achieve detailed patient grouping based on baseline features and event sequences.
• The system's visualizations, including timelines, heatmaps, and progression views, provide actionable insights for optimizing clinical decision-making.

Introduction

The paper "TrialView: An AI-powered Visual Analytics System for Temporal Event Data in Clinical Trials" (2310.04586) presents a system designed to address the complex challenges in visualizing and analyzing temporal event data from randomized controlled trials (RCTs). The system, TrialView, integrates graph-based AI with visual analytics to facilitate the exploration and summarization of individual and cohort data in clinical trials, particularly focusing on the Participant event sequences and cohort patterns.

System Architecture and Features

The TrialView system is structured to provide users with four interconnected views: Individual, Cohort, Progression, and Statistics. Each view is designed to enable detailed examination and interpretation of RCT data from different perspectives. The system employs advanced techniques such as graph neural networks (GNNs) and graph transformers for clustering participants and interpreting their clinical and demographic characteristics. A graph Grad-CAM model is also utilized for explainability, identifying significant baseline features that contribute to clustering outcomes. This implementation allows TrialView to deliver a robust multi-faceted visual analytics experience to its users.

Methodological Advancements

TrialView incorporates several methodological advancements to achieve its primary objectives:

1. Data Clustering: TrialView employs both data-driven and knowledge-guided strategies to cluster patients according to their baseline features and event sequences. The data-driven approach leverages a graph transformer autoencoder to map patient similarities based on baseline data and temporal sequences into a richly informative latent space, which is subsequently used for clustering. Conversely, the knowledge-guided approach uses Ward's hierarchical clustering, informed by clinical domain expertise, to organize patients based on predefined criteria.
2. Visualization: The system introduces an innovative way to visualize temporal transitions and patterns within clinical datasets. It uses timeline-based charts, heatmaps, and distribution graphs to represent both individual and cohort data. The dashboard-like interface increases the interpretability of complex datasets for clinical researchers and care providers.
3. Explanatory Modeling: The application of the graph Grad-CAM (Gradient-weighted Class Activation Mapping) model aids in elucidating the significance of specific baseline features. This contributes to understanding the underlying mechanisms that define patient clusters, offering healthcare professionals actionable insights into the data.

Practical Applications and Case Study

The system's utility is demonstrated through a case study involving Alcoholic Hepatitis data from the AlcHepNet consortium. This study illustrates how TrialView allows clinical investigators to track disease progression and assess treatment efficacy at both individual and cohort levels. The graphical representation of survival analysis, event progression, and cohort statistics empowers stakeholders to derive insights for optimizing clinical strategies and decision-making processes.

Implementation Considerations

The backend of TrialView uses Python, Flask, and PyTorch, while the frontend employs React and D3.js for an interactive and seamless user interface. The use of RESTful APIs facilitates efficient communication between the frontend and backend, ensuring a responsive user experience. Importantly, the system's architecture is robust, allowing easy adaptation to other domains with similar temporal event data.

Conclusion

TrialView provides a highly effective solution for the visual analysis of temporal event data in clinical trials, fulfilling the needs of diverse stakeholders including clinical trialists, care providers, and researchers. By synthesizing advanced AI models with visual analytics, it enables users to explore, interpret, and derive meaningful conclusions from complex datasets. Future enhancements include the introduction of user-defined cluster models to expand applicability across various clinical scenarios. TrialView stands as a valuable tool, potentially extensible to other sectors requiring temporal data analysis, such as healthcare and business intelligence.